MENU

CUE Cue Biopharma Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals

Industry Biotechnology
CUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
CUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CUE is expected to report earnings to fall 36.76% to -10 cents per share on March 12

Cue Biopharma CUE Stock Earnings Reports
Q4'24
Est.
$-0.11
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.04
Q4'23
Est.
$-0.28
The last earnings report on November 14 showed earnings per share of -17 cents, beating the estimate of -18 cents. With 37.67K shares outstanding, the current market capitalization sits at 90.31M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
40 Guest Street
Phone
+1 617 949-2680
Employees
53
Web
https://www.cuebiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

CUE and Stocks

Correlation & Price change

A.I.dvisor tells us that CUE and PRME have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CUE and PRME's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
N/A
PRME - CUE
31%
Poorly correlated
-9.22%
AVTE - CUE
29%
Poorly correlated
-2.66%
RIGL - CUE
29%
Poorly correlated
+0.18%
ACLX - CUE
28%
Poorly correlated
-5.05%
PCVX - CUE
28%
Poorly correlated
-4.09%
More

Groups containing CUE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
N/A
biopharmaceuticals
theme (50 stocks)
26%
Poorly correlated
-2.60%
drugs
theme (254 stocks)
23%
Poorly correlated
-1.67%
biotechnology
theme (238 stocks)
12%
Poorly correlated
-1.76%